In 2014, the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) reported a multi-stage schizophrenia genome-wide association study (PGC2 GWAS) of up to 36,989 cases and 113,075 controls. They identified 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance (Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510):421-427. [PMID: 25056061]).
    If you used this data, please cite the reletive reference.